Barclays Has Lowered Expectations for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLX) had its target price cut by equities researchers at Barclays from $140.00 to $139.00 in a report issued on Thursday,Benzinga reports. The brokerage currently has an “underweight” rating on the stock. Barclays‘s price target indicates a potential downside of 3.43% from the stock’s current price.

Several other equities research analysts have also commented on the company. DA Davidson reduced their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. JPMorgan Chase & Co. increased their price target on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Wells Fargo & Company raised their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $159.50.

Clorox Stock Up 1.5 %

CLX stock opened at $143.94 on Thursday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. Clorox has a 1-year low of $127.60 and a 1-year high of $171.37. The stock has a market capitalization of $17.73 billion, a P/E ratio of 39.34, a P/E/G ratio of 2.62 and a beta of 0.45. The business has a fifty day moving average price of $151.92 and a 200-day moving average price of $159.31.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the firm earned $2.16 earnings per share. Equities analysts forecast that Clorox will post 7.15 earnings per share for the current fiscal year.

Institutional Trading of Clorox

Institutional investors have recently added to or reduced their stakes in the company. Integral Investment Advisors Inc. lifted its stake in shares of Clorox by 4.1% during the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after acquiring an additional 67 shares during the last quarter. HCR Wealth Advisors raised its position in Clorox by 1.0% during the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after purchasing an additional 68 shares in the last quarter. Sound View Wealth Advisors Group LLC raised its holdings in shares of Clorox by 6.1% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock valued at $218,000 after acquiring an additional 77 shares in the last quarter. Wedbush Securities Inc. lifted its position in shares of Clorox by 1.2% in the 4th quarter. Wedbush Securities Inc. now owns 7,624 shares of the company’s stock worth $1,238,000 after purchasing an additional 94 shares during the period. Finally, Brooklyn Investment Group boosted its stake in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.